AORT vs C · rev $388.5M vs P/E 16, rev $85.22B
Artivion Inc (AORT) versus Citigroup Inc. (C) — a side-by-side from cached financials, not a winner call.
Artivion Inc (AORT) is a medical devices company listed on US.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Latest reported AORT revenue for 2024-12-31 was $388.5M. Net income was -$13.4M. Revenue was up 9.8% from 2023-12-31 to 2024-12-31. AORT currently screens at market cap $1.45B.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
AORT currently screens at market cap $1.45B. C currently screens at market cap $214.73B and trailing P/E 15.5.
Not investment advice. Open the AORT and C stock pages for the full models.
Not investment advice.